Alpha-1, Antitrypsin

Alpha-1 Antitrypsin Deficiency Market to Register Incremental Growth by 2032, Assesses DelveInsight | Key Companies - Kamada Pharmaceuticals, Arrowhead Pharmaceuticals, Takeda, Mereo BioPharma, AstraZeneca, Inhibrx, Novo Nordisk

Published on 08/07/2025 at 18:04 | prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom Ireland


+91-9650213330
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/alpha-1-antitrypsin-deficiency-market-to-register-incremental-growth-by-2032-assesses-delveinsight--key-companies---kamada-pharmaceuticals-arrowhead-pharmaceuticals-takeda-mereo-biopharma-astrazeneca-inhibrx-novo-nordisk-302038163.html

en | boerse | 67980005 |